These data suggest that the increased expression of OPN may facilitate the development and/or progression of NSCLC, and it is possible that OPN could be used as either a therapeutic target or a biomarker for NSCLC in the future. This evidence concerns the gene SPP1 and non-small cell lung carcinoma.